BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18297446)

  • 1. Simple and rapid determination of serum carbapenem concentrations by high-performance liquid chromatography.
    Kurihara Y; Kizu J; Hori S
    J Infect Chemother; 2008 Feb; 14(1):30-4. PubMed ID: 18297446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection.
    Legrand T; Chhun S; Rey E; Blanchet B; Zahar JR; Lanternier F; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):551-6. PubMed ID: 18848512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an HPLC method for the determination of doripenem in human and mouse serum.
    Sutherland C; Nicolau DP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):123-6. PubMed ID: 17392039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid, sensitive high performance liquid chromatographic method for the determination of meropenem in pharmaceutical dosage form, human serum and urine.
    Ozkan Y; Küçükgüzel I; Ozkan SA; Aboul-Enein HY
    Biomed Chromatogr; 2001 Jun; 15(4):263-6. PubMed ID: 11438968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of meropenem levels in human serum by high-performance liquid chromatography with ultraviolet detection.
    Roth T; Fiedler S; Mihai S; Parsch H
    Biomed Chromatogr; 2017 May; 31(5):. PubMed ID: 27797104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography.
    Myers CM; Blumer JL
    Antimicrob Agents Chemother; 1984 Jul; 26(1):78-81. PubMed ID: 6591852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic assay for meropenem in serum.
    Elkhaïli H; Niedergang S; Pompei D; Linger L; Leveque D; Jehl F
    J Chromatogr B Biomed Appl; 1996 Nov; 686(1):19-26. PubMed ID: 8953188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study.
    Dailly E; Bouquié R; Deslandes G; Jolliet P; Le Floch R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1137-42. PubMed ID: 21474395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of meropenem in plasma by high-performance liquid chromatography and a microbiological method.
    al-Meshal MA; Ramadan MA; Lotfi KM; Shibl AM
    J Clin Pharm Ther; 1995 Jun; 20(3):159-63. PubMed ID: 7593377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Column-switching high-pressure liquid chromatographic method for the determination of a new carbapenem antibiotic, L-739,428, in rat and monkey plasma.
    Wong BK; Bruhin PJ; Lin JH
    J Chromatogr B Biomed Appl; 1994 Apr; 655(1):158-62. PubMed ID: 8061826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients.
    Garcia-Capdevila L; López-Calull C; Arroyo C; Moral MA; Mangues MA; Bonal J
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):127-32. PubMed ID: 9187391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation on administration method of carbapenems].
    Mikamo H; Ninomiya M; Tamaya T
    Jpn J Antibiot; 2002 Dec; 55(6):875-81. PubMed ID: 12621741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urine.
    Musson DG; Birk KL; Cairns AM; Majumdar AK; Rogers JD
    J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):99-106. PubMed ID: 9892072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
    Kiratisin P; Keel RA; Nicolau DP
    Int J Antimicrob Agents; 2013 Jan; 41(1):47-51. PubMed ID: 23127484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem.
    Mattoes HM; Kuti JL; Drusano GL; Nicolau DP
    Clin Ther; 2004 Aug; 26(8):1187-98. PubMed ID: 15476901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen.
    Ishihara N; Nishimura N; Tamaki H; Karino F; Miura K; Isobe T; Ikawa K; Morikawa N; Naora K
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):422-9. PubMed ID: 25828635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR; Frei CR; Burgess DS
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of imipenem and meropenem in human plasma and its application in TDM.
    Zou L; Meng F; Hu L; Huang Q; Liu M; Yin T
    J Pharm Biomed Anal; 2019 May; 169():142-150. PubMed ID: 30861406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-injection HPLC assay for the determination of a new carbapenem antibiotic in human plasma and urine.
    Zhang J; Musson DG; Birk KL; Cairns AM; Fisher AL; Neway W; Rogers JD
    J Pharm Biomed Anal; 2002 Feb; 27(5):755-70. PubMed ID: 11814717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.